CARDINAL HEALTH, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102.7 USD | -0.10% |
|
-3.90% | +2.17% |
| 12:10pm | Morgan Stanley Adjusts Cardinal Health's Price Target to $114 From $117, Maintains Overweight Rating | MT |
| Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows:
- distribution of pharmaceutical products (92.7%);
- distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.).
The United States accounts for 97.7% of net sales.
Sector
Pharmaceuticals
Calendar
2024-05-01
- Q3 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
102.8
USD
Average target price
112.9
USD
Spread / Average Target
+9.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.17% | 25.01B | |
| +14.73% | 69.29B | |
| +2.20% | 8.36B | |
| +5.20% | 8.16B | |
| -20.43% | 7.69B | |
| +0.73% | 4.53B | |
| +16.98% | 4.47B | |
| -2.00% | 3.99B | |
| -2.89% | 3.88B | |
| +21.87% | 3.66B |
- Stock Market
- Equities
- CAH Stock
- News Cardinal Health, Inc.
- Credit Suisse Lowers Cardinal Health's PT to $50 from $53 After FQ1 Results Miss Estimates, Keeps Neutral Rating
